Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2013
11/20/2013CN103393736A Pharmaceutical composition for treating alzheimer disease and preparation method as well as application thereof
11/20/2013CN103393735A Poacynum hendersonii woodson leaf total flavones dispersible tablet and preparation method thereof
11/20/2013CN103393733A Centella asiatica (l.) urban effective fraction and application thereof
11/20/2013CN103393730A Oral ginkgo biloba extract liquid and preparation method thereof
11/20/2013CN103393725A Application of bacillus subtilis BS01 for improving sleep
11/20/2013CN103393722A Pain relieving injection
11/20/2013CN103393705A Application of scutellarin in preparing medicines for preventing and treating Alzheimer's disease
11/20/2013CN103393702A Drug composition for enhancing memory of people rapidly exposed to high altitude, and preparation method thereof
11/20/2013CN103393700A Application of doxycycline in preparing medicines for enhancing PAC1-R (Pituitary Adenylate Cyclase Activating Polypeptide Type 1 Receptor) dimer dependent constitutive activity
11/20/2013CN103393695A Methods and compositions for treatment and management of multiple myeloma
11/20/2013CN103393691A Anti-inflammatory agents
11/20/2013CN103393681A Methodand composition for treatment and management of multiple myeloma
11/20/2013CN103393671A Extracting and refining method of ginkgolide
11/20/2013CN103393640A Application of Sarcaboside B to antidepressant medicament
11/20/2013CN103393625A Application of fungus polyketide in preparation of medicine used for treating alzheimer disease
11/20/2013CN103393623A Novel preparation
11/20/2013CN103393619A Vinpocetine soft capsule, and preparation method and application thereof
11/20/2013CN103393618A Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing same
11/20/2013CN103393615A Duloxetine enteric pellet and preparation method thereof
11/20/2013CN103393614A Perospirone hydrochloride sustained release preparation and preparation method thereof
11/20/2013CN103393607A Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
11/20/2013CN103393596A Metronidazole suspension and preparation method thereof
11/20/2013CN103393595A Pharmaceutical composition of edaravone
11/20/2013CN103393594A Novel aripiprazole preparation composition
11/20/2013CN103393590A Nano ganoderma spore oil and production process and application thereof
11/20/2013CN103393097A Health food with effects of sobering and protecting liver
11/20/2013CN103392873A Food-grade health tea soluble granules capable of nourishing brain
11/20/2013CN103392872A Food-grade health tea soluble granules capable of improving sleep
11/20/2013CN102924303B Tapentadol hydrochloride crystal form C, and preparation method and application thereof
11/20/2013CN102824470B Medicinal liquor for treating proplapse of lumbar intervertebral disc, ischialgia and leg pain
11/20/2013CN102784349B Method for preparing traditional Chinese medicine for treating insomnia caused by overfeeding oily food
11/20/2013CN102784236B Method for preparing traditional Chinese medicine for treating insomnia caused by anger
11/20/2013CN102755535B Oral liquid for improving high sleep quality
11/20/2013CN102716152B Method for processing horn-type medicinal materials
11/20/2013CN102688454B Medicinal composition for treating Alzheimer disease, as well as preparation method and application thereof
11/20/2013CN102631579B Oral Chinese herbal preparation for treating post-traumatic brain syndrome
11/20/2013CN102600370B Application of Chinese medicinal composition in preparing medicament for preventing and treating Parkinsonism
11/20/2013CN102579791B Medicine with drug abstinence function and preparation thereof
11/20/2013CN102526520B Medicament for treating epilepsy and preparation method thereof
11/20/2013CN102406897B Xingnaojing solid medicinal composition and preparation method thereof
11/20/2013CN102382806B TAT-WNK102 transmembrane protein and application thereof
11/20/2013CN102276447B Naproxen hydrate crystal, preparation method thereof and medicinal composition containing naproxen hydrate crystal and sumatriptan
11/20/2013CN102274274B Self-microemulsifiable kudzu root flavone oral micro-pill composition and preparation method thereof
11/20/2013CN102274176B Nimodipine injection composition, and preparation method and application thereof
11/20/2013CN102245573B Heteroaryl derivatives as cftr modulators
11/20/2013CN102171189B Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
11/20/2013CN102048734B Pharmaceutical composition
11/20/2013CN101884766B Healthcare product or medicine for preventing diabetes complication and senium and preparation method thereof
11/20/2013CN101874782B Sustained-release microballoons of dihydroetorphine or salt thereof and injection type prolonged action preparation thereof
11/20/2013CN101712626B Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
11/20/2013CN101444621B Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (FGE)
11/19/2013US8586775 Therapeutic compounds and methods of use
11/19/2013US8586706 Peptide vaccine using mimic molecules of amyloid β peptide
11/19/2013US8586605 Fused amino pyridine as HSP90 inhibitors
11/19/2013US8586588 Aryl pyridazinone derivatives and their use as H3 receptor ligands
11/19/2013US8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/19/2013US8586581 Ethynyl compounds useful for treatment of CNS disorders
11/19/2013US8586524 Modulators of pharmacological agents
11/19/2013US8586332 Method for producing oligopolysaccharides
11/19/2013US8586088 Tamper-resistant oral opioid agonist formulations
11/19/2013US8586086 Hydrogel capable of containing and conveying cells
11/19/2013CA2786330C A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
11/19/2013CA2746307C Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
11/19/2013CA2603030C Benzyloxypropylamine derivative
11/19/2013CA2595043C Use of oxycodone for treating visceral pain
11/19/2013CA2473987C Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
11/14/2013WO2013170186A1 Carbazole-containing sulfonamides as cryptochrome modulators
11/14/2013WO2013170115A1 Pyridazine and pyridine derivatives as nampt inhibitors
11/14/2013WO2013169964A1 Heteroaryl compounds and methods of use thereof
11/14/2013WO2013169907A1 Alpha 7 nicotinic acetylcholine allosteric modulators, their derivatives and uses thereof
11/14/2013WO2013169889A1 Alpha 7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
11/14/2013WO2013169741A1 Agents and devices for affecting nerve function
11/14/2013WO2013169600A1 Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
11/14/2013WO2013168826A1 Method for screening for prophylactic or therapeutic agent for diseases or disorders associated with inflammation-related feedback loop
11/14/2013WO2013168693A1 Method for producing sepiapterin and tetrahydrolactoylpterin
11/14/2013WO2013168627A1 CRYSTALS OF 5'-O-α-D-GLUCOPYRANOSYLADENOSINE HYDROCHLORIDE AND USE THEREOF
11/14/2013WO2013168315A1 Therapeutic or prophylactic agent for dementia and behavioral and psychological symptoms
11/14/2013WO2013168174A1 Apoe4 antibodies for treatment of neurodegenerative conditions
11/14/2013WO2013168131A1 Intrathecal administration of mtor inhibitors for the therapy of neurodegenerative, neuroinflammatory and neurooncologic diseases
11/14/2013WO2013168126A1 Crystalline forms of vilazodone hydrochloride and vilazodone free base
11/14/2013WO2013168090A1 Geranium oil and constituents thereof for treatment of neurodegenerative diseases
11/14/2013WO2013168033A1 Compositions and methods for treatment of neurologic diseases
11/14/2013WO2013168024A1 Prodrugs of anti-platelet agents
11/14/2013WO2013168023A1 Compositions and methods for treatment of parkinson's disease
11/14/2013WO2013168021A1 Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
11/14/2013WO2013168019A1 Compositions and methods for the treatment of neuropathic pain
11/14/2013WO2013168014A1 Compositions and methods for the treatment of familial amyloid polyneuropathy
11/14/2013WO2013168011A1 Compositions and methods for the treatment of chronic pain
11/14/2013WO2013168010A1 Compositions and methods for treatment of severe pain
11/14/2013WO2013168008A1 Compositions and methods for the treatment of neurological diseases
11/14/2013WO2013168007A1 Compositions and methods for the treatment of cardiovascular and neurological diseases
11/14/2013WO2013168003A1 Compositions and methods for the treatment of inflammation
11/14/2013WO2013168002A1 Compositions and methods for the treatment of neurological conditions
11/14/2013WO2013168000A1 Compositions and methods for the treatment of severe pain
11/14/2013WO2013167993A1 Compositions and methods for the treatment of neurological degenerative disorders
11/14/2013WO2013167992A1 Compositions and methods for the treatment of inflammatory disorders
11/14/2013WO2013167990A1 Compositions and methods for the treatment of depression
11/14/2013WO2013167988A1 Compositions and methods for the treatment of cough
11/14/2013WO2013167985A1 Compositions and methods for the treatment of neurological disorders
11/14/2013WO2013167635A1 Therapeutic use of indole-dihydro-imidazole derivatives
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 1833